Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Caren Deardorf is Director at Alpha Cognition. OQRO lists 2 transactions filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Alpha CognitionACOG
2 disclosures · Nov 2026
Nov 11, 2026755disclosed Nov 13
DetailsOfficial recordNov 11, 20261,020disclosed Nov 13
DetailsOfficial recordAs of the latest filing on , Caren Deardorf reported holding 755 shares of Alpha Cognition (ACOG), worth about $6.3K at the last close of $8 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Alpha Cognition ACOG | 755 | 755 direct | $8 | $6.3K | Nov 11, 2026 |
Is this Caren Deardorf’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Caren Deardorf has no open-market purchase on record since 2021. Sales in 1 of the 6 years since 2021.
Caren Deardorf reported 0 open-market purchases and 1 sale since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2021 | — | $42K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 11, 2026, Caren Deardorf reported holding 755 shares of Alpha Cognition (ACOG). At the last close of $8 on Nov 13, 2026, that is about $6.3K. This is the stake disclosed in filings, not a net worth.
Caren Deardorf has no open-market purchase on record since 2021. Sales in 1 of the 6 years since 2021.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2021.
Dianthus Therapeutics, Inc. (DNTH), from 2021 to 2021: 0 purchases and 1 sale.
Caren Deardorf reported 0 open-market purchases and 1 sale here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
